Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen

• OHNO Masasuke

  Department of Neurosurgery, Nagoya University School of Medicine

• NATSUME Atsushi

  Department of Neurosurgery, Nagoya University School of Medicine

• IWAMI Ken-ichiro

  Department of Neurosurgery, Nagoya University School of Medicine

• IWAMIZU Hidetaka

  Department of Neurosurgery, Nagoya University School of Medicine

• NORITAKE Kana

  Department of Neurosurgery, Nagoya University School of Medicine

• ITO Daiki

  Department of Neurosurgery, Nagoya University School of Medicine

• TOI Yuki

  Department of Neurosurgery, Nagoya University School of Medicine

• ITO Motokazu

  Department of Neurosurgery, Nagoya University School of Medicine

• MOTOMURA Kazuya

  Department of Neurosurgery, Nagoya University School of Medicine

• YOSHIDA Jun

  Department of Neurosurgery, Nagoya University School of Medicine

• YOSHIKAWA Kazuhiro

  Center for Genetic and Regenerative Medicine, Nagoya University School of Medicine

• WAKABAYASHI Toshihiko

  Department of Neurosurgery, Nagoya University School of Medicine

収録刊行物

• Cancer science

  Cancer science 101 (12), 2518-2524, 2010-12-10

詳細情報

• CRID: 1572543026128051072
• NII論文ID: 10027834208
• NII書誌ID: AA11808050
• ISSN: 13479032
• Web Site: https://search.jamas.or.jp/link/ui/2011238680
• 本文言語コード: en
• データソース種別:
  • CiNii Articles